Clinical effect of vascular smooth muscle electrical stimulation and triamcinolone acetonide of the patients with vulvar lichen sclerosus
LIU Nian1 ZHAO Junda1 LIU Ya2 MA Junqi1
1.Department of Gynecology, the First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi 830000, China; 2.Department of Gynecology, Heze Municipal Hospital, Shandong Province, Heze 274000, China
Abstract：Objective To compare the effect of vascular smooth muscle electrical stimulation and triamcinolone acetonide in the treatment of vulvar lichen sclerosus. Methods A total of 58 patients with vulvar lichen sclerosus in the First Affiliated Hospital of Xinjiang Medical University from January 2015 to January 2020 were selected, they were divided into physical therapy group (21 cases) and drug therapy group (37 cases) according to follow-up conditions and wills. In physical therapy group, the vascular and lymphatic systems of the lower limbs and pelvic floor were treated with electrical stimulation, and drug therapy group was treated with Triamcinolone Acetonide Cream. Symptom and sign scores and quality of life index scores before treatment and 1, 3, 6, and 12 months after treatment were compared between two groups, and the occurrence of adverse reactions was observed. Results The symptom scores of physical therapy group were lower than those of drug therapy group at 12 months after treatment (P < 0.05). Sign scores of physical therapy group were higher than those of drug therapy group at 1 month after treatment (P < 0.05). The quality of life scores of physical therapy group were lower than those of drug therapy group at 1 and 6 months after treatment (P < 0.05). Sexual life scores of physical therapy group were lower than those of drug therapy group at 3,6, and 12 months after treatment (P < 0.05). The sleep anxiety scores of physical therapy group were lower than those of drug therapy group at 1, 6 and 12 months after treatment (P < 0.05). In the physical therapy group, one patient with diabetes developed vulvovaginal candidiasis, which was cured after treatment and continued treatment; in drug therapy group, two patients had local itching aggravation, prickling, redness, and swelling, and stopped taking the medicine. In the long-term medication follow-up, five patients showed unalleviated pruritus, local vascular dilation, pigmentation, and adverse drug reactions, and drug withdrawal. Conclusion Vascular smooth muscle electrical stimulation is safe and effective in the treatment of vulvar lichen sclerosus with few side effects. It has advantages in improving sexual life quality, skin pigment, and sleep anxiety recovery.
刘念1 赵骏达1 刘娅2 马俊旗1. 平滑肌电刺激与曲安奈德治疗外阴硬化性苔藓的临床效果[J]. 中国医药导报, 2022, 19(15): 105-108.
LIU Nian1 ZHAO Junda1 LIU Ya2 MA Junqi1. Clinical effect of vascular smooth muscle electrical stimulation and triamcinolone acetonide of the patients with vulvar lichen sclerosus. 中国医药导报, 2022, 19(15): 105-108.
[1] 中国医疗保健国际交流促进会妇儿医疗保健分会外阴阴道疾病项目专家委员会.女性外阴硬化性苔藓临床诊治专家共识（2021年版）[J].中国实用妇科与产科杂志，2021，37（1）：70-74.
[2] Cattaneo A，Bracco GL，Maestrini G，et al. Lichen sclerosus and squamous hyperplasia of the vulva. A clinical study of medical treatment [J]. J Reprod Med，1991，36：301-305.
[3] Felmingham C，Chan L，Doyle LW，et al. The Vulval Disease Quality of Life Index in women with vulval lichen sclerosus correlates with clinician and symptom scores [J]. Australas J Dermatol，2020，61（2）：110-118. DOI：10.1111/ajd.13197.
[4] Aygin D，Aslan FE. The Turkish adaptation of the female sexual function index [J]. Turkiye Klinikleri J Med Sci，2005，25：393-399.
[5] Ulusoy M，Sahin NH，Erkmen H. Turkish version of Beck anxiety inventory：psychometric properties [J]. J Cogn Psychother，1998，12（2）：163.
[6] Y?覦ld?覦z ■，Cengiz H，Kaya C，et al. Evaluation of genital self-image and sexual dysfunction in women with vulvar lichen planus or lichen sclerosus [J]. J Psychosom Obstet Gynaecol，2020，10：18. DOI：10.1080/0167482X.2020.1857359.
[7] Ranum A，Pearson DR. Acitretin therapy for vulvar lichen sclerosus complicated by recurrent squamous cell carcinoma [J]. JAAD Case Rep，2020，8：53-55. DOI：10.1016/j.jdcr.2020.12.009.
[8] Singh N，Ghatage P. Etiology，Clinical Features，and Diagnosis of Vulvar Lichen Sclerosus：A Scoping Review [J]. Obstet Gynecol Int，2020，2020：7480754. DOI：10.1155/2020/7480754.
[9] Pergialiotis V，Bellos I，Biliou EC，et al. An arm-based network meta-analysis on treatments for vulvar lichen sclerosus and a call for development of core outcome sets [J]. Am J Obstet Gynecol，2020，222（6）：542-550.e6. DOI：10.1016/j.ajog.2019.10.095.
[10] Corazza M，Virgili A，Minghetti S，et al. Dyspareunia in vulvar lichen sclerosus：an overview of a distressing symptom [J]. G Ital Dermatol Venereol，2020，155（3）：299-305. DOI：10.23736/S0392-0488.17.05849-7.
[11] 李静然，隋龙，吴瑞芳，等.外阴鳞状上皮内病变诊治专家共识[J].中国妇产科临床杂志，2020，21（4）：441-445.
[12] 史宏晖，朱兰，杨毅，等.高能聚焦超声与皮质激素治疗外阴上皮内非瘤样病变的多中心随机对照研究[J].中华医学杂志，2013，93（41）：3291-3293.
[13] 李静然，王建六.点阵式激光在硬化性苔藓治疗中的应用[J].中国妇产科临床杂志，2020，20（1）：21-24.
[14] Mendieta-Eckert M，Torrontegui Bilbao J，Zabalza Estévez I，et al. Treatment of Vulvar Lichen Sclerosus et Atrophicus With Fractional Carbon Dioxide Laser Therapy：A Report of 4 Cases [J]. Actas Dermosifiliogr（Engl Ed），2021，112（1）：85-88. DOI：10.1016/j.ad.2019.03.021.
[15] 耿庆娜，付旭晖，吴丹丹，等．73例女性硬化性苔藓临床及病理分析[J].皮肤性病诊疗学杂志，2020，27（1）：1-4. DOI：10.3969/j.issn.1674-8468.2020.01.001
[16] Krapf JM，Mitchell L，Holton MA，et al. Vulvar Lichen Sclerosus：Current Perspectives [J]. Int J Womens Health，2020，12：11-20. DOI：10.2147/IJWH.S191200.
[17] Cleminson K，Baxter ML. Vulvar lichen sclerosus [J]. CMAJ，2021，193（40）：E1572. DOI：10.1503/cmaj.210448.
[18] 张洁，王影，冯艳霞，等.血管平滑肌电刺激技术治疗外阴上皮内非瘤样病变疗效观察[J].中国实用妇科与产科杂志，2017，33（1）：125-128.
[19] Pretty M. The Clinical Role of LASER for vulvar and vaginal treatments in gynecology and female urology：an ICS/ISSVD best practice consensus document [J]. J Low Genit Tract Dis，2019，23（2）：151-160.
[20] Singh N，Mishra N，Ghatage P. Treatment Options in Vulvar Lichen Sclerosus：A Scoping Review [J]. Cureus，2021， 13（2）：e13527. DOI：10.7759/cureus.13527.
[21] Corazza M，Schettini N，Zedde P，et al. Vulvar Lichen Sclerosus from Pathophysiology to Therapeutic Approaches：Evidence and Prospects [J]. Biomedicines，2021，9（8）：950. DOI：10.3390/biomedicines9080950.
[22] Orszulak D，Dulska A，Niziński K，et al. Pediatric Vulvar Lichen Sclerosus-A Review of the Literature [J]. Int J Environ Res Public Health，2021，18（13）：7153. DOI：10.3390/ijerph18137153.
[23] Kolitz E，Gammon L，Mauskar M. Vulvar lichen sclerosus in women of reproductive age [J]. Proc（Bayl Univ Med Cent），2021，34（3）：349-351. DOI：10.1080/08998280. 2021.1885093.
[24] Zhang F，Li D，Shi L，et al. 5-ALA-photodynamic therapy in refractory vulvar lichen sclerosus et atrophicus [J]. Int J Clin Exp Pathol，2020，13（12）：3100-3110.
[25] Corazza M，Toni G，Valpiani G，et al. Does longer duration of corticosteroid treatment improve clearance in vulvar lichen sclerosus? Results from a single centre，comparative，open label study [J]. Dermatol Ther，2021，34（4）：e14955. DOI：10.1111/dth.14955.
京公网安备 11010502046598号